Abstract
The mesolimbic dopaminergic system is a neuroanatomical key structure for reward and motivation upon which previous studies indicated that antidepressant drugs exert a stimulatory influence, via still unknown neurobiological mechanisms. Here we examined the effects of chronic administration of antidepressants of several classes (amitriptyline, desipramine, imipramine, fluoxetine and tranylcypromine) and repeated electroconvulsive shock treatments (ECT) on dopamine D3 receptor expression in the shell of the nucleus accumbens, a major projection area of the mesolimbic dopaminergic system. Short-term drug treatments had variable effects on D3 receptor mRNA expression. In contrast, treatments for 21 days (with all drugs except fluoxetine) significantly increased D3 receptor mRNA expression in the shell of nucleus accumbens; D3 receptor binding was also significantly increased by amitriptyline or fluoxetine after a 42-day treatment. ECT for 10 days increased D3 receptor mRNA and binding in the shell of nucleus accumbens. D1 receptor and D2 receptor mRNAs were increased by imipramine and amitriptyline, but not by the other treatments. The time-course of altered D3 receptor expression, in line with the delayed clinical efficiency of antidepressant treatment, and the fact that various antidepressant drugs and ECT treatments eventually produced the same effects, suggest that increased expression of the D3 receptor in the shell of nucleus accumbens is a common neurobiological mechanism of antidepressant treatments, resulting in enhanced responsiveness to the mesolimbic dopaminergic system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Koob GF . Drugs of abuse: anatomy, pharmacology and function of reward pathways Trends Pharmacol Sci 1992; 13: 177–184
Salamone JD . The involvement of nucleus accumbens dopamine in appetitive and aversive motivation Behav Brain Res 1994; 61: 117–133
Kapur S, Mann J . Role of the dopaminergic system in depression Biol Psychiatry 1992; 32: 1–17
Brown AS, Gershon S . Dopamine and depression J Neural Transm Gen Sect 1993; 91: 75–109
Fibiger HC . Neurobiology of depression: focus on dopamine Adv Biochem Psychopharmacol 1995; 49: 1–17
Willner P . The mesolimbic dopamine system as a target for rapid antidepressant action Int Clin Psychopharmacol 1997; 12: (Suppl 3) S7–S14
Silverstone T . Dopamine in manic depressive illness. A pharmacological synthesis J Affect Dis 1985; 8: 225–231
Gessa GL, Pani L, Serra G, Fratta W . Animal models of mania Adv Biochem Psychopharmacol 1995; 49: 43–66
Markou A, Koob GF . Postcocaine anhedonia. An animal model of cocaine withdrawal Neuropsychopharmacology 1991; 4: 17–26
Belmaker RH, Wald D . Haloperidol in normals Br J Psychiatry 1977; 131: 222–223
D'Haenen HA, Bossuyt A . Dopamine D2 receptors in depression measured with single photon emission computed tomography Biol Psychiatry 1994; 35: 128–132
Shah PJ, Ogilvie AD, Goodwin GM, Ebmeier KP . Clinical and psychometric correlates of dopamine D2 binding in depression Psychol Med 1997; 27: 1247–1256
Zung WW . Review of placebo-controlled trials with bupropion J Clin Psychiatry 1983; 44: 104–114
Kinney JL . Nomifensine maleate: a new second-generation antidepressant Clin Pharmacol 1985; 4: 625–636
Garattini S . Pharmacology of amineptine, an antidepressant agent acting on the dopaminergic system: a review Int Clin Psychopharmacol 1997; 12 Suppl. 3: S15–S19
Maj J, Rogoz Z, Skuza G, Sowinska H . Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine J Pharm Pharmacol 1984; 36: 127–130
Chiodo LA, Bunney BS . Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons J Neurosci 1983; 3: 1607–1619
White FJ, Wang RY . Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons Science 1983; 221: 1054–1057
Papp M, Klimek V, Willner P . Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine Psychopharmacology 1994; 115: 441–446
Ichikawa J, Meltzer HY . Effect of antidepressants on striatal and accumbens extracellular dopamine levels Eur J Pharmacol 1995; 281: 255–261
Stewart J, Rajabi H . Initial increases in extracellular dopamine in the ventral tegmental area provide a mechanism for the development of desimipramine-induced sensitization within the midbrain dopamine system Synapse 1996; 23: 258–264
Barkai Al, Durkin M, Nelson HD . Localized alterations of dopamine receptor binding in rat brain by repeated electroconvulsive shock: an autoradiographic study Brain Res 1990; 529: 208–213
Nomikos GG, Zis AP, Damsma G, Fibiger HC . Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat striatum: an in vivo microdialysis study Neuropsychopharmacology 1991; 4: 65–69
Smith SE, Sharp T . Evidence that the enhancement of dopamine function by repeated electroconvulsive shock requires concomitant activation of D1-like and D2-like receptors Psychopharmacology 1997; 133: 77–84
Sokoloff P, Giros B, Martres M-P, Bouthenet M-L, Schwartz J-C . Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics Nature 1990; 347: 146–151
Lévesque D, Diaz J, Pilon C, Martres M-P, Giros B, Souil E et al. Identification, characterization and localization of the dopamine D3 receptor in rat brain using 7-[3H]-hydroxy-N, N di-n-propyl-2-aminotetralin Proc Natl Acad Sci USA 1992; 89: 8155–8159
Heimer L, Alheid GF, de Olmos JS, Groenewegen HJ, Haber SN, Harlan RE et al. The accumbens: beyond the core-shell dichotomy J Neuropsychiatry Clin Neurosci 1997; 9: 354–381
Maj J, Dziedzicka-Wasylewska M, Rogoz E, Rogoz Z . Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain Eur J Pharmacol 1998; 351: 31–37
Bordet R, Ridray S, Carboni S, Diaz J, Sokoloff P, Schwartz J-C . Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa Proc Natl Acad Sci USA 1997; 94: 3363–3367
Ridray S, Griffon N, Souil E, Mignon V, Carboni S, Diaz J et al. Coexpression of dopamine D1 and D3 receptors in rat ventral striatum: opposite and synergistic functional interactions Eur J Neurosci 1998; 10: 1676–1686
Porsolt RD, Anton G, Blavet N, Jalfre M . Behavioral despair in rats: a new model sensitive to antidepressant treatments Eur J Pharmacol 1978; 47: 379–391
Steru L, Chermat R, Thierry B, Simon P . The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl) 1985; 85: 367–370
Dziedzicka-Wasylewska M, Rogoz R, Klimek V, Maj J . Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain J Neural Transm 1997; 104: 515–524
Dziedzicka-Wasylewska M, Willner P, Papp M . Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment Behav Pharmacol 1997; 8: 607–618
Ainsworth K, Smith SE, Zetterstrom TS, Franklin M, Sharp T . Effects of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat Psychopharmacology (Berl) 1998; 140: 470–477
Le Moine C, Bloch B . Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors Neuroscience 1996; 73: 131–143
Walker PD, Riley LA, Hart HP, Jonakait GM . Serotonin regulation of tachykinin biosynthesis in the rat neostriatum Brain Res 1991; 546: 33–39
Shirayama Y, Mitsushio H, Takashima M, Ichikawa H, Takahashi K . Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat Brain Res 1996; 739: 70–78
Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors Science 1998; 281: 1640–1645
Maj J, Papp M, Skuza G, Bigajska K, Zazula M . The influence of repeated treatment with imipramine, (+)- and (−)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists J Neural Transm 1989; 76: 29–38
Serra G, Collu M, D'Aquila PS, De Montis MG, Gessa GL . Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants Brain Res 1990; 527: 234–243
Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG et al. Selection inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist Nature 1999; 400: 371–375
Gurevich EV, Himes JW, Joyce JN . Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja J Pharmacol Exp Ther 1999; 289: 587–598
Willner P, Muscat R, Papp M . Chronic mild stress-induced anhedonia: a realistic animal model of depression Neurosci & Biobehav Rev 1992; 16: 525–534
Anisman H, Zacharko RM . Depression as a consequence of inadequate neurochemical adaptation in response to stressors Br J Psychiatry 1992; 15: 36–43
Risch SC . Recent advances in depression research: from stress to molecular biology and brain imaging J Clin Psychiatry 1997; 58 Suppl 5: 3–6
Agid O, Shapira B, Zislin J, Ritsner M, Hanin B, Murad H et al. Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia Mol Psychiatry 1999; 4: 163–172
Harkness KL, Monroe SM, Simons AD, Thase M . The generation of life events in recurrent and non-recurrent depression Psychol Med 1999; 29: 135–144
Thierry A-M, Tassin J-P, Blanc G, Glowinski J . Selective activation of mesocortical DA systems by stress Nature 1976; 263: 242–244
Finlay JM, Zigmond MJ . The effects of stress on central dopaminergic neurons: possible clinical implications Neurochem Res 1997; 22: 1387–1394
Gambarana C, Masi F, Tagliamonte A, Scheggi S, Ghiglieri O, De Montis GM . A chronic stress that impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study J Neurochem 1999; 72: 2039–2046
Chiodo LA, Antelman SM . Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity Nature 1980; 287: 451–454
Chiodo LA, Antelman SM . Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment Science 1980; 210: 799–801
Ainsworth K, Smith SE, Zetterstrom TS, Pei Q, Franklin M, Sharp T . Effects of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens Psychopharmacology 1998; 140: 470–477
Brown EE, Nomikos GG, Wilson C, Fibiger HC . Chronic desimipramine enhances the effect of locally applied amphetamine on interstitial concentrations of dopamine in the nucleus accumbens Eur J Pharmacol 1991; 202: 125–127
Prisco S, Esposito E . Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area Br J Pharmacol 1995; 116: 1923–1931
Grenhoff J, Nisell M, Ferre S, Aston-jones G, Svensson TH . Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat J Neural Transm Gen Sect 1993; 93: 11–25
Lévesque D, Martres M-P, Diaz J, Griffon N, Lammers CH, Sokoloff P et al. A paradoxical regulation of the dopamine D3 receptor expression suggests that involvement of an anterograde factor from dopamine neurons Proc Natl Acad Sci USA 1995; 92: 1719–1723
Seroogy KB, Lundgren KH, Tran T, Guthrie KM, Isackson PJ, Gall CM . Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs J Comp Neurol 1994; 342: 321–334
Altar CA, Di Stefano PS . Anterograde transport of neurotrophins in the nervous systems Trends Neurosci 1998; 21: 433–437
Guillin O, Damier L, Griffon N, Diaz J, Carroll P, Schwartz J-C et al. Role of brain-derived neurotrophic factor in the control of D3 receptor expression Eur J Neuropsychopharmacol 1999; 9: S184–S185
Smith MA, Makino S, Kvenansky R, Post RM . Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus J Neurosci 1995; 15: 1768–1777
Nibuya M, Morinobu S, Duman RS . Regulation of BDNF and TrkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J Neurosci 1995; 15: 7539–7547
Sautel F, Griffon N, Lévesque D, Pilon C, Schwartz JC, Sokoloff P . A functional test identifies dopamine agonists selective for D3 versus D2 receptors NeuroReport 1995; 6: 329–332
Mierau J, Schneider FJ, Ensinger HA, Chio CL, Lajiness ME, Huff RM . Pramipexole binding and activation of cloned and expressed dopamine D2, D3, D4 receptors Eur J Pharmacol 1995; 290: 29–36
Maj J, Rogoz Z, Skuza G, Kolodziejczyk K . Antidepressant effects of pramipexole, a novel dopamine receptor agonist J Neural Transm 1997; 104: 525–533
Willner P, Lappas S, Cheeta S, Muscat R . Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole Psychopharmacol (Berl) 1994; 115: 454–462
Goldberg JF, Frye MA, Dunn RT . Pramipexole in refractory bipolar depression Am J Psychiatry 1999; 156: 798
Szegedi A, Wetzel J, Hillert A, Kleiser E, Gaebel W, Benkert O . Pramipexole, a novel selective dopamine agonist in major depression Mov Disord 1996; 11: (Suppl.1) 266
Paxinos G, Watson C . The Rat Brain in Stereotaxic Coordinates, 2nd edn Academic Press: New York 1986
Author information
Authors and Affiliations
Additional information
See also the Image page, Molecular Psychiatry 2000; 5: 229
Rights and permissions
About this article
Cite this article
Lammers, CH., Diaz, J., Schwartz, JC. et al. Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments. Mol Psychiatry 5, 378–388 (2000). https://doi.org/10.1038/sj.mp.4000754
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000754
Keywords
This article is cited by
-
A longitudinal study of the association between basal ganglia volumes and psychomotor symptoms in subjects with late life depression undergoing ECT
Translational Psychiatry (2021)
-
The Effects of Chronic Amitriptyline on Zebrafish Behavior and Monoamine Neurochemistry
Neurochemical Research (2018)
-
Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment`
Psychopharmacology (2017)
-
Retinal dysfunction of contrast processing in major depression also apparent in cortical activity
European Archives of Psychiatry and Clinical Neuroscience (2015)
-
Assessing the Roles of Stimulants/Stimulant-like Drugs and Dopamine-agonists in the Treatment of Bipolar Depression
Current Psychiatry Reports (2013)